Anchyra Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Anchyra Partners's MRK Position: Q3 2026 in Review
Anchyra Partners increased its Merck (MRK) stake by 11% in Q3 2026, buying an estimated $144K and bringing the position to 10,791 shares worth $1.57M. The position accounts for 0.33% of the portfolio, ranked #57.
Anchyra Partners first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Anchyra Partners held 10,791 shares of Merck worth $1.57M as of Q3 2026.
- Anchyra Partners bought 1,045 Merck shares in Q3 2026, an estimated $144K.
- Merck made up 0.33% of Anchyra Partners's portfolio in Q3 2026, its #57 holding.
- Anchyra Partners first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.